June 18, 2026 Retatrutide and the New Metabolic Frontier: UCHealth Report Highlights Next-Generation Peptides Reshaping Obesity Medicine — A California Trim Clinic Perspective
June 18, 2026 F2G and Shionogi Announce Positive Topline Results From Global Phase 3 OASIS Study Evaluating Oral Olorofim Versus AmBisome® Followed by Standard of Care in Patients With Invasive Aspergillosis
June 18, 2026 U.S. News & World Report and Argentum Enter into a Strategic Resident Engagement Research and Media Partnership